Stay updated on Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe NCT03571620 record is displayed, describing the completed Phase 2 study of Q301 cream for atopic dermatitis, including its design, eligibility criteria, location, and outcome measures.SummaryDifference36%

- Check13 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the study record page remains unavailable with a 403 Forbidden message.SummaryDifference0.2%

- Check20 days agoChange DetectedAn NIH-wide banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence.” The study-record area otherwise shows a 403 error.SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check34 days agoChange DetectedThe error page’s footer revision label changes from v3.7.0 to v3.7.1; the 403 message and page layout remain unchanged.SummaryDifference0.2%

- Check55 days agoChange DetectedA 403 Forbidden error page now appears where the study record would be displayed, indicating that access to the record is blocked. This reflects an access restriction or site issue rather than a content update.SummaryDifference16%

Stay in the know with updates to Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.